MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

Meeting: 2016 International Congress

Abstract Number: 571

Keywords: Parkinsonism, Scales

Session Information

Date: Tuesday, June 21, 2016

Session Title: Technology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor signs in patients with Parkinson’s disease (PD).

Background: The requirement for face-to-face evaluation of patients when administering the Unified Parkinson’s disease Rating Scale (UPDRS) limits ability to collect patient data due to logistical issues including mobility, travel, and time. What is needed is a simple, reliable, and secure means of remotely collecting clinical and clinical research data.

Methods: Sixteen participants with PD were trained to record a self-administered 11 item short version UPDRS (svUPDRS) using an iPod touch™ device. In-office recordings were made at baseline and week 4 for comparison with in-person UPDRS rating, and patients uploaded 3 interim weekly home recordings of the svUPDRS to a HIPAA-compliant cloud-based platform using CaptureProof™ technology.

Results: Mean age of participants was 67 ± 8 years; there were 9 men and 7 women; mean education was 18 ± 2 years; and 13/16 reported daily smart phone use. Mean PD duration was 6.4 ± 2.8 years; mean UPDRS Part III in the “on” state was 25 ± 9.7 points. Fourteen of the 16 participants had 100% compliance with scheduled home recording activities, and successfully recorded and uploaded 98% of the modules at the 3 pre-specified weekly intervals. One participant withdrew due to illness, and 1 completed only the baseline visit. One participant required retraining, but was subsequently able to complete the study. Pearson Correlation Coefficient at visits 1 and 4 for recorded svUPDRS versus equivalent items from the in-person in-office ratings was 0.68 (p=0.008). Participants reported both technological and logistical barriers to home video-recording including difficulty using the iPod touch small screen, and the need for a partner for iPod touch™ recording.

Conclusions: Use of home-based video-recordings for remotely rating motor function in PD is feasible, and requires study in a larger cohort. Correlation of video-based svUPDRS ratings with “traditional” in-person rating is good, and results of this pilot study will guide modifications in training participants and recording parameters. We predict that this approach will enhance data collection in PD clinical trials involving testing new therapeutics for motor control.

To cite this abstract in AMA style:

J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe. Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/testing-feasibility-and-utility-of-remote-data-capture-technology-to-assess-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/testing-feasibility-and-utility-of-remote-data-capture-technology-to-assess-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley